Master no. 0272-00351697 UBS AG Tel +41-31-33621 11
EXHIBIT 10.101
Master no. 0272-00351697 |
||
UBS AG | ||
P.O. Box, 3011 Bern | ||
Tel x00-00-00000 11 | ||
xxx.xxx.xxx |
UBS Corporate Financing
1. Borrower
Staar Surgical AG
Xxxxxxxxxxxx 000
0000 Xxxxx
(hereinafter referred to as the ‘Borrower’)
2. Lender
UBS AG
Barenplatz &
3011 Berne
(hereinafter referred to as ‘UBS’)
3. Credit facility
UBS grants the Borrower a credit facility in a maximum amount of 3 750 000 CHF (Swiss Francs three million seven hundred and fifty thousand).
4. Financing purpose
5. Availability
• | as a current account overdraft in CHF and/or any freely-available and convertible currency | |
• | as UBS fixed advances with terms of 1 — 12 months in an amount of at least 250 000 CHF and/or the equivalent in any freely-available and convertible currency. |
6. Interest rates and commission
6.1 UBS current accounts
Plus credit commission in the amount of 0.25% per quarter based on the average debit balance.
At the end of each calendar quarter, a closing statement showing interest and commission charges shall be provided. UBS shall have the right to adjust interest and commission rates to changing market conditions at any time with immediate effect.
75341 E V5 03.3 | 530581061 | Page 1/6 |
Master no. 0272-00351697 |
6.2 UBS fixed advances
For any advance with a term of more than 6 months, interest shall be calculated and charged quarterly at the end of each calendar quarter. Principal and interest shall be calculated and charged at maturity.
The base interest rate shall be calculated according to Euromarket rates for the relevant term and currency, plus a UBS margin.
The interest rate shall be fixed two bank working days prior to any advance being drawn down or renewed, for the corresponding term and currency. The instructions for drawdown or renewal must be received by UBS at least two bank working days before such drawdown or renewal. Where such instructions are unavailable, advances falling due will not be renewed and both principal and interest will be debited from the relevant current account.
6.3 Interest calculation
7. Reduction of credit line/amortization
8. Security
1) Assignment of all accounts receivable, pursuant to separate form «General Purposes Assignment of Claims (Global Assignment)».
9. Term
10. Termination
10.1 Ordinary termination
UBS shall have the right to terminate this Credit Agreement at any time with immediate effect, and to refuse to make funds available to the Borrower under the credit facility at its discretion, without having to provide any reasons.
Any termination shall cancel the unused portion of the credit facility with immediate effect. To the extent that the credit facility has been drawn down, any outstanding amounts shall become due and payable as follows:
• | UBS current account | |||
immediately | ||||
• | UBS fixed advance | |||
on expiration of the agreed term |
75341 E V5 03.3 | 530581061 | Page 2/6 |
Master no. 0272-00351697 |
10.2 Extraordinary termination
UBS shall have the right to terminate this Credit Agreement at any time with immediate effect, and to declare all outstanding amounts including accrued interest, commission, fees, etc. immediately due and payable, irrespective of the term of any credit facility granted, if:
1) | the Borrower or a Group company («Group company» shall hereinafter mean any company within the meaning of Art. 663 lit. e, para. 1 of the Swiss Code of Obligations that may be deemed to belong to the Borrower’s consolidated group of companies) is more than 30 calendar days in arrears with payment of interest, commission and/or principal payments owed to UBS or a third party (including any parties that may have acquired claims under the credit granted), or fails to reduce overdrafts by repayment or providing sufficient additional security within the time period set therefor by UBS. | |||
2) | the Borrower or one of its Group companies is/are required by official order (in particular in the area of environmental protection) to undertake remedial measures which are deemed by UBS as having a potentially material effect on the Borrower’s ability to perform its financial obligations. | |||
3) | in the opinion of UBS a material reduction in the value of security is imminent or has occurred. | |||
4) | there has been a change of ownership/controlling interests in relation to the Borrower which UBS deems to be material. | |||
5) | the Borrower or a Group company changes its/their legal or commercial structure, e.g. through liquidation, sale of a substantial part of its assets, change of its objects or business activities, merger or restructuring, provided that the relevant event is deemed by UBS as having a potentially material effect on the Borrower’s ability to perform its financial obligations. | |||
6) | with regard to the Borrower or a Group company bankruptcy proceedings or a stay of bankruptcy proceedings are filed and/or an application for court or out-of-court creditor protection is made. | |||
7) | the Borrower or a Group company has suspended payments or the earnings or asset position of the Borrower or a Group company is deemed by UBS to have deteriorated significantly. | |||
8) | the Borrower or a Group company is in breach of any other obligations arising under this Credit Agreement. |
11. Indemnity in the event of premature repayment
If, in connection with any extraordinary termination, UBS declares that capital drawn down is due for repayment prior to maturity, the Borrower shall be liable to indemnify UBS for all loss suffered and/or costs incurred as a result, in particular for any difference between the agreed interest rate and the rate obtainable at the time of the premature repayment on an investment in the money or capital market with the same period remaining to maturity. UBS reserves the right to claim additional compensation.
75341E V5 03.3 | 530581061 | Page 3/6 |
Master no. 0272-00351697 |
12. Representations and warranties
1) | the Borrower has not created any security interest in respect of its own obligations and/or the obligations of third parties other than security given under this Credit Agreement or in the context of other credit agreements with UBS and/or any security given in favour of other creditors with respect to which the Borrower has expressly notified UBS. | |||
2) | no event has occurred which would entitle UBS to effect extraordinary termination, and no legal action is pending which could have a material adverse effect on the Borrower or its assets. |
13. Negative covenants
Furthermore, the Borrower shall not grant any security in the above-mentioned manner in favour of any third parties. If the Borrower is part of a group, it shall not grant any security in favour of any companies controlled directly or indirectly by it and/or any third parties. The Borrower shall moreover ensure that any companies controlled directly or indirectly by it do not grant any security in the above-noted manner in favour of any third parties or any other companies controlled directly or indirectly by it. This provision shall not apply to security provided for obligations arising under this Credit Agreement.
No sale/transfer to third parties or other group companies or any other changes of the participations and/or other assets and/or the worldwide patents and licenses (especially but not limited to the product lines “ICL”, “IOL” and “Aquaflow”) owned by the Borrower as of December 31, 2003, without the prior written consent of UBS.
No new intercompany receivables deriving from “financial or non-commercial transactions”, compared with the situation as of April 2, 2004 (1 062 029 USD), without the prior written consent of UBS.
New/additional receivables against group companies have to derive from “commercial transactions” such as the delivery of merchandise. The terms of payment of such intercompany receivables may not exceed 90 days.
14. Financial ratios
1) | Equity. | |
Minimum equity of the Borrower according to the audited financial statements as of the end of each business year not below 12 000 000 USD. Equity is defined as “common stock + retained earnings + reserves”. |
15. Information undertaking
1) | one copy of the balance sheet and profit and loss statement, including any appendices, together with the auditor’s report, by no later than four months following the close of the fiscal year (separate and consolidated). |
75341 E V5 03 3 | 530581061 | Page 4/6 |
Master no. 0272-00351697 |
2) | one copy of the budget, including the investment budget, by no later than 30 calendar days prior to commencement of the relevant fiscal year. |
The Borrower undertakes, for the entire term of this credit facility, to immediately inform UBS of any material changes, in particular of the occurrence, or likely occurrence, of any circumstances which might constitute grounds for extraordinary termination.
16. Conditions precedent
• | one copy of this Credit Agreement | |
• | General Purposes Assignment of Claims (Global Assignment) | |
• | Repledging of Your Collateral |
In the event that UBS has not received all of the documents and/or security, in the required form, within one month of the date of execution of this Credit Agreement, UBS shall be authorized to rescind this Credit Agreement without granting any extension of the deadline for receiving the said documents and/or security.
17. Miscellaneous provisions
17.1 General conditions
The «General Conditions» of UBS shall form an integral part of this Credit Agreement
17.2 Order in which security will be realized
17.3 Confirm auditors
18. Transfer
All assignees shall be entitled to reassign the rights acquired, provided that each subsequent assignee also undertakes to maintain secrecy. UBS (and any party acquiring rights as a result of any transfer made in accordance with this Clause) may, without having to obtain consent from the Borrower, assign any limit obligation agreed under this Credit Agreement, and/or any other obligations arising hereunder, to the assignee in respect thereof, together with any claims under the credit granted. Any party acquiring such obligations must either be a company affiliated with UBS, or a Swiss or foreign financial institution (bank, insurance company, or similar). UBS shall be released from any obligation to the extent that it transfers same.
75341 E V5 03.3 | 530581061 | Page 5/6 |
Master no. 0272-00351697 |
19. Waiver of set-off
20. Applicable law and jurisdiction
This Agreement was executed in three original copies and replaces all agreements made between the parties to this date.
Ref. P2M4-HID
|
UBS AG | ||
Berne, 2nd August 2004 |
|||
/s/ Xxxxxx Xxxxxxx | /s/ Xxxxxxx Xxxxxxxxxxx | ||
Place/Date
|
Xxxxxx Xxxxxxx | Xxxxxxx Xxxxxxxxxxx | |
Agreed | |||
Borrower
|
Staar Surgical AG | ||
Place/Date |
Signature(s) | ||
Staar Surgical Company, Monrovia USA | |||
Place/Date
|
Signature(s) |
75341 E V5 03.3 | 530581061 | Page 6/6 |